With the opening of the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, the Gladstone Institutes has taken a major step forward in accelerating protein research.
News and Highlights
Revelations about a key cellular pathway have important implications for neurodegenerative diseases like ALS and frontotemporal dementia.
The new strategy is more sustainable and less risky than the current standard therapies.
Prime Minister Shinzo Abe spoke about the value of collaboration between the US and Japan—particularly in the fields of science and technology.
Finding could have implications for other autoimmune disorders, such as type I diabetes.
Scientists have discovered why some heart tissue turns into bone, and they may have learned how to stop it.
Groundbreaking discovery challenges the conventional theory that infected host cells control latency and could open the door to new pathways.
Raising levels of the life-extending protein klotho can protect against learning and memory deficits in a mouse model of Alzheimer’s disease, despite the accumulation of Alzheimer-related toxins in the brain.
By helping cells switch their type, we may have discovered a new way to repair damaged hearts, and potentially revolutionize the future of medicine.
Protein interactions between viruses and cells can illuminate common weak points in human biology and reveal potential new targets for antiviral treatments.